Accelerant Holdings Acquired by Thoma Bravo in $4B Deal

Accelerant Holdings shares jumped 43.4% on August 13, 2026, closing at $19.52 after the specialty insurance platform announced a definitive $4 billion all-cash acquisition by private equity firm Thoma Bravo. The deal, which offers shareholders $20.25 per share, coincides with a second-quarter earnings report that saw the company double analyst profit expectations [1, 4].

Buyout terms and earnings performance

The acquisition price of $20.25 per share represents a 49% premium over the company’s closing price on August 12, 2026 [4]. Thoma Bravo has provided a full equity commitment to fund the transaction, which carries no financing conditions [4]. Entities affiliated with Altamont Capital Partners, holding approximately 82% of the company's voting rights, have already agreed to support the merger, a move that analysts suggest significantly lowers the risk of the deal failing to close [4].

The market reaction was further amplified by a strong second-quarter financial performance. Accelerant reported adjusted earnings per share of $0.32, doubling the $0.16 consensus estimate [4]. Revenue for the quarter reached $356.9 million, exceeding Wall Street forecasts by more than 30% [4]. Net income rose to $80.0 million, a substantial increase from the $13.1 million reported in the same quarter of the previous year [4]. Trading volume surged to 69.1 million shares, roughly 2,131% higher than the stock's three-month average of 3.1 million shares [1].

Market context and sector reaction

The broader market showed modest gains during the session, with the S&P 500 rising 0.65% and the Nasdaq Composite climbing 0.82% [1]. Within the specialty insurance and risk exchange sector, performance was mixed; Aon shares rose 1.39%, while Ryan Specialty Holdings fell 0.12% [3]. Following the announcement, William Blair downgraded Accelerant stock from Outperform to Market Perform, citing the limited remaining upside as the share price converged toward the $20.25 buyout offer [4].

Accelerant, which went public in 2025, has experienced significant volatility, having fallen 26% from its IPO price prior to this announcement [1]. The company’s stock had traded as low as $9.18 over the past 52 weeks before the buyout news triggered a rapid repricing [2, 4].

What to watch

• Regulatory and Shareholder Approval: The deal is expected to close in the first half of 2027, pending necessary approvals [1, 4].
• Ticking Fee Provision: Shareholders are protected by a 6% per annum ticking fee if regulatory delays push the closing timeline beyond expected milestones [4].
• Sector Consolidation: Continued monitoring of specialty insurance brokerage valuations, specifically how rivals like Aon and Ryan Specialty Holdings respond to the removal of a key data-driven competitor from the public markets [1, 3].

The acquisition marks a transition for the company back to private ownership, with CEO Jeff Radke stating the move will allow the firm to leverage Thoma Bravo’s strategic resources to further scale its data-fueled insurance platform [1]. With the stock trading within 4% of the offer price, the market is signaling high confidence that the transaction will proceed as planned [1].